Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials".
Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China; Department of Biopharmaceutical, Yulin Normal University, Yulin 537000, China.
De-Qi
DQ
Jiang
Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Ming-Xing
MX
Li
Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China. Electronic address: yongwh2005@hotmail.com.
Yong
Y
Wang
D002219:Carbamates / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*
D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; D008687:Metformin